Nektar Therapeutics director sells $23,400 in company stock By Investing.com
SAN FRANCISCO, CA – Nektar Therapeutics (NASDAQ:) director, Robert Chess, has sold a total of 19,500 shares of company stock,…
Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment
(Reuters) - Nektar Therapeutics on Monday sued Eli Lilly, accusing the drugmaker of undermining the prospects for Rezpeg, which Nektar…
